Arévalo MFG, Badía FJJ

Language: Spanish
References: 11
Page: 180-182
PDF size: 120.77 Kb.

Text Extraction

No abstract

REFERENCES

1. Van der Horst-Bruinsma IE, Nurmohamed MT, Landewé RB. Comorbidities in patients with spondyloarthritis. Rheum Dis Clin North Am. 2012; 38(3): 523-538.

2. Rubin LA, Amos CI, Wade JA et al. Investigating the genetic basis for ankylosing spondylitis: Linkage studies with the major histocompatibility complex region. Arthritis Rheum. 1994; 37: 1212.

3. Jarvinen P. Ocurrence of ankylosing spondylitis in a nationwide series of twins. Arthritis Rheum. 1995; 38: 381.

4. Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol. 1989; 16: 792.

5. Zheng MQ, Wang YQ, Lu XY, Wang YL, Mao LP, Gu YF, Chen PF. Clinical analysis of 240 patients with HLA-B27 associated acute anterior uveitis. Yan Ke Xue Bao. 2012; 27(4): 169-172.

6. Esterberg E, Acharya NR. Corticosteroid-sparing therapy: practice patterns among uveitis specialists. J Ophthalmic Inflamm Infect. 2012; 2(1): 21-28.

7. Sallam A, Taylor SR, Lightman S. Review and update of intraocular therapy in noninfectious uveitis. Curr Opin Ophthalmol. 2011; 22(6): 517-522.

8. Simonini G, Paudyal P, Jones GT, Cimaz R, Macfarlane GJ. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology (Oxford). 2012; 52(5): 825-831.

9. Kotaniemi k, Säilä H, Kautiainen H. Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis. Clin Ophthalmol. 2011; 5: 1425-1429.

10. Diaz-Llopis M, Salom D, Garcia-de-Vicuña C et al. Treatment of refractory uveitis with adalimubab: a prospective multicenter study of 131 patients. Ophthalmology. 2012; 119(8): 1575-1581.

11. Matsuda J, Kaburaki T, Kobayashi S, Numaga J. Treatment of recurrent anterior uveitis with infliximab in patients with ankylosing spondylitis. Jpn J Ophthalmol. 2013; 57(1): 104-107